Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

5.0%

1 terminated/withdrawn out of 20 trials

Success Rate

93.8%

+7.2% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 15 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

N/A
17(85.0%)
Phase 1
2(10.0%)
Phase 2
1(5.0%)
20Total
N/A(17)
Phase 1(2)
Phase 2(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (20)

Showing 20 of 20 trials
NCT03847701Not ApplicableCompleted

Cardio-metabolic and Inflammatory Impact of Starch Digestibility in Type 2 Diabetic Patients

Role: collaborator

NCT07035964Not ApplicableRecruiting

Effects of Effera Human Lactoferrin at One Dose Compared to Placebo on Gut Permeability

Role: collaborator

NCT05585762Not ApplicableCompleted

Buck Institute Ketone Ester RCT

Role: collaborator

NCT06098001Not ApplicableUnknown

Bioavailability Study of Hemp Phenolics

Role: collaborator

NCT04423302Not ApplicableCompleted

Effect of Totum-63 on Glucose and Lipid Homeostasis in Subjects With Dysglycemia (REVERSE-IT)

Role: collaborator

NCT04760951Not ApplicableCompleted

Effect of Totum-070 on Lipid Metabolism in Moderate Hypercholesterolemic Subjects

Role: collaborator

NCT02221687Not ApplicableTerminated

The Combiotic-Study

Role: collaborator

NCT05117385Not ApplicableUnknown

The Effect of the Consumption of 4 Botanical Extracts on Immunity in Healthy Adults (B-4-Immune)

Role: collaborator

NCT03698318Not ApplicableCompleted

Pharmacokinetics Assessing Bioavailability of Gingerols and Shogaols of Five Ginger Extracts

Role: collaborator

NCT03692806Not ApplicableCompleted

Efficacy of STABLOR® on Visceral Fat Mass Reduction in Patients With Metabolic Syndrome

Role: collaborator

NCT02868177Phase 2Completed

Effect of Totum-63, Active Ingredient of Valedia, on Glucose and Lipid Homeostasis on Subjects With Prediabetes

Role: collaborator

NCT03276663Not ApplicableCompleted

Growth of Healthy Term Infants Fed a Partially Hydrolyzed Follow-up Formula

Role: collaborator

NCT03289494Not ApplicableCompleted

Evaluation of 2 Diets With Different Starch Digestibility Profiles on Daily Glycemic Profile, in T2D Patients

Role: collaborator

NCT03813550Not ApplicableUnknown

Intestinal Microbiota and Vitamin K Levels in PXE Patients (IMPROVE Study)

Role: collaborator

NCT03621865Not ApplicableCompleted

A Comparative Pharmacokinetic Study to Evaluate the Ability of a New Formulation to Enhance Curcuminoids Bioavailability

Role: collaborator

NCT03707002Not ApplicableCompleted

Effect of scFOS on Increase in Stool Frequency in Constipated People

Role: collaborator

NCT03052062Phase 1Completed

Tolerance Study of the Dietary Supplement Lipidrive (ECPH1-03)

Role: collaborator

NCT02989753Phase 1Completed

Effects of Two Herbal Dietary Supplements on Lipid Metabolism in Moderate Hypercholesterolemia and Hypertriglyceridemia

Role: collaborator

NCT02817620Not ApplicableCompleted

Study to Assess Antioxidant Efficacy of Spirulina on oxLDL and Lipids Metabolism on Subjects With Metabolic Syndrome

Role: collaborator

NCT02016703Not ApplicableCompleted

Gastrointestinal Tolerance of Erythritol-containing Beverages in Young Children

Role: collaborator

All 20 trials loaded